Back

PDGFR-beta variant as a causal driver of myxomatous mitral valve degeneration

17 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular mechansism of cardiomyopathies and valvular disease Valvular Heart Disease Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Maroua El Ouraoui

Leiden University Medical Center, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Mutational mapping of sequence variants within the arginine- and serine-rich (RS) domain of RBM20
Mrs J. Gross (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Single-nucleus RNA-sequencing profiles suggest metabolic differences in a cardiomyocyte subset in DSG2 murine model of arrhythmogenic cardiomyopahty
Mrs A. Serrecchia (Padova, IT)
Abstract
Presentation thumbnail
MiRNA-19b targets mineralocorticoid receptor and prevents calcification of female valve interstitial cells
Doctor E. Jover (Pamplona, ES)
Abstract
Presentation thumbnail
Upregulation of the PD-1 pathway in non-ICI myocarditis
Ms A. Sijtema (Rotterdam, NL)
Abstract

Access the full session

Session thumbnail
Molecular mechansism of cardiomyopathies and valvular disease

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April - 19 April 2026
You may be interested in
thumbnail
Congress Presentation
Transcatheter therapies for structural heart disease: where are we in 2023?
thumbnail
Congress Session
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
thumbnail
Congress Presentation
The importance of severe valvular disease in patients with acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources